| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |